-
-
-
-
-
-
-
Jefferies finds AI drives up to 50% cost cuts in drug development
-
-
-
-
-
-
-
RBC Capital Starts Medpace (MEDP) at Outperform
-
-
-
-
-
-
-
After-hours movers: ON Semiconductor, Credo, Upwork, Regenxbio, and more
-
-
-
-
-
-
-
UBS Downgrades Medpace (MEDP) to Sell
-
-
-
-
-
-
-
William Blair Downgrades Medpace (MEDP) to Market Perform 'Due to Challenging Demand Environment'
-
-
-
-
-
-
-
Baird Downgrades Medpace (MEDP) to Neutral
-
-
-
-
-
-
-
Jefferies Downgrades Medpace (MEDP) to Hold
-
468,194 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

